|
 |
| Molecular Pathology • Molecular Hematopathology
|
|
Molecular Hematopathology
|
|
|
 |
Molecular Hematopathology provides comprehensive molecular testing for patients with benign and malignant disorders of the lymph nodes, peripheral blood, and bone marrow. Our state-of-the-art diagnostic techniques assist in establishing a diagnosis, predicting prognosis, and/or guiding the choice of therapy and monitoring for a range of benign and malignant hemotolymphoid disorders affecting pediatric and adult patients.
Testing performed includes clonality studies for lymphoproliferative disorders, mutational analysis for acute myeloid leukemias, minimal residual disease monitoring and mutation analysis in chronic myeloid leukemia, mutation testing for myeloproliferative neoplasms, and thalassemia/hemoglobinopathy testing. Numerous fluorescence in situ hybridization assays are available to detect molecular cytogenetic abnormalities associated with myeloid and lymphoid neoplasms. Our spectrum of services is designed to be flexible, from performing a single test to full-service consultation depending on the needs of each client and each case.
Results of molecular testing are correlated with the corresponding morphologic findings where appropriate, and an integrated interpretation is provided. Our pathologists also provide expert assistance in test selection and interpretation of unusual findings.
In addition to their excellence in clinical service, faculty have research interests in a wide variety of hematolymphoid disorders. The faculty also participates in a variety of cooperative groups, multinational consortiums, and national level continuing education programs.
Disease Listings:
|
 |
|
Molecular Hematopathology Staff
|
|
 |
 |
James Cook, MD, PhD
Section Head, Molecular Hematopathology
Board Certifications: Hematology, Anatomic Pathology
Specialty Interest: Hematopathology
Phone: 216.444.4435
Email: cookj2@ccf.org
|
 |
David Bosler, MD
Head, Cleveland Clinic Laboratories
Board Certifications: Anatomic Pathology, Clinical Pathology, Hematopathology, Molecular Genetic Pathology
Specialty Interests: Leukemia and lymphoma diagnosis, molecular diagnostics in hematology
Phone: 216.636.9615
Email: boslerd@ccf.org
|
 |
Claudiu Cotta, MD, PhD
Associate Director, Pathology Residency Program
Board Certifications: Hematology, Anatomic Pathology, Clinical Pathology
Specialty Interest: Hematopathology
Phone: 216.444.4588
Email: cottac@ccf.org
|
 |
Eric Hsi, MD
Chair, Clinical Pathology; Section Head, Hematopathology
Board Certifications: Anatomic Pathology, Clinical Pathology, Hematopathology
Specialty Interests: Hematopathology, immunophenotyping, molecular diagnostics
Phone: 216.444.5230
Email: hsie@ccf.org
|
 |
Armin Jegalian, MD, PhD
Board Certifications: Anatomic Pathology, Clinical Pathology, Hematopathology
Specialty Interest: Hematopathology
Phone: 216.636.9601
Email: jegalia@ccf.org
|
 |
Raymond Tubbs, DO
Medical Director, Cleveland Clinic Laboratories; Section Head, Molecular Oncologic Pathology
Board Certifications: Molecular Genetic Pathology, Hematology, Anatomic Pathology, Clinical Pathology
Specialty Interests: Molecular pathology, hematopathology
Phone: 216.444.2844
Email: tubbsr@ccf.org
|
|
|
|
|
|
|